ELANElanco Animal Health Incorporated

$12B

FY 2016 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$2.9B+0.2% YoY

Gross Profit

$1.3B45.8% margin

Operating Income

$283M9.7% margin

Net Income

-$48M-1.6% margin

EPS (Diluted)

$-0.13

Cash Flow

Operating Cash Flow

$156M

Free Cash Flow

$46M

Stock-Based Comp.

$20M

Balance Sheet

Total Assets

$8.1B

Total Liabilities

$1.1B

Stockholders' Equity

$7.0B

Cash & Equivalents

$259M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2.9B	$2.9B	+0.2%
Gross Profit	$1.3B	$1.2B	+10.0%
Operating Income	$283M	$5M	+5144.4%
Net Income	-$48M	-$211M	+77.3%

ELAN FY 2016 Earnings — Elanco Animal Health Incorporated Revenue & Financial Results | Market Cap Arena